Unleashing the power of p53: lessons from mice and men: Figure 1.
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
References http://www.genesdev.org/cgi/content/full/20/2/125#References This article cites 55 articles, 20 of which can be accessed free at: service Email alerting click here top right corner of the article or Receive free email alerts when new articles cite this article sign up in the box at the Topic collections (46 articles) Cancer and Disease Models Articles on similar topics can be found in the following collections
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 1×
“Furthermore, Nutlins can suppress growth of established tumor xenographs in nude mice to the same extent as treatment with doxorubicin (Vassilev et al. 2004).”
BackgroundSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“A higher amount of Mdm2 would both degrade the extra p53 protein and also the other negative regulator of p53, MdmX GENES & DEVELOPMENT 127 (Chen et al. 2005; Okamoto et al. 2005; Pereg et al. 2005), thus bringing p53 down to levels found in wild-type cells, but such p53 would be relatively more…”
BackgroundStructure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · cited 1×
“The remarkable fact that the Mdm2–p53 interaction is mediated by three hydrophobic residues (Kussie et al. 1996) suggested that Mdm2 might be a suitable target for small compounds that could uncouple p53 and Mdm2, leading to elevation in p53 activity (Moll and Zaika 2000; Vassilev 2004).”
BackgroundAmplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · cited 1×
“In general, protein–protein interactions are viewed as poor targets for drug design due to the fact that protein complexes usually have large interacting surfaces not easily disturbed by small molecules (Arkin and Wells 2004).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“…maintaining the p53–Mdm2–MdmX circuitry, perhaps the most compelling being the fact that it is not possible to produce viable Mdm2- or Mdmx-null mice unless either are generated in a p53-null background (Jones et al. 1995; Montes de Oca Luna et al. 1995; Parant et al. 2001; Migliorini et al. 2002).”
BackgroundRescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265 · cited 3×
“A landmark study from the group of A. Levine has shed new light on the mechanism of Mdm2 overexpression in some hereditary and sporadic tumors (Bond et al. 2004).”
BackgroundResultp53 isoforms can regulate p53 transcriptional activity
Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810 · cited 1×
“In fact, it is now known that, like its p63 and p73 homologs, p53 can be expressed as multiple isoforms (including p44) with different N and C termini that are likely to have different activities and interactions (Bourdon et al. 2005; Mills 2005; Prives and Manfredi 2005; Rohaly et al. 2005).”
BackgroundMDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641 · cited 1×
“Understanding the relationship between these genes is not merely an academic question (even though as such it is a fascinating one); about half of all human tumors express wild-type p53, and a significant proportion of these cancers overexpress Mdm2 (Momand et al. 2000).”
BackgroundModulation of mammalian life span by the short isoform of p53
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586 · cited 6×
“There is at present a fairly strong connection between cellular senescence and aging in animals (Campisi 2005), and thus the data in the Scrable study (Maier et al. 2004) have provided significant insight into the premature aging phenotype of mice containing both full-length and truncated p53 proteins.”
BackgroundInfluentialParant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517 · cited 1×
“…maintaining the p53–Mdm2–MdmX circuitry, perhaps the most compelling being the fact that it is not possible to produce viable Mdm2- or Mdmx-null mice unless either are generated in a p53-null background (Jones et al. 1995; Montes de Oca Luna et al. 1995; Parant et al. 2001; Migliorini et al. 2002).”
BackgroundOverexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
Jones, S. N., Hancock, A. R., Vogel, H., Donehower, L. A., & Bradley, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15608 · Cited by 386
Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
Böttger, A., Böttger, V., Sparks, A., Liu, W.-L., Howard, S. F., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00374-5 · Cited by 363 · cited 2×
“Alignment of the peptides also revealed the consensus sequence for binding to Mdm2 (PxFxDYWxxL) (Bottger et al. 1996, 1997).”
BackgroundMigliorini, D., Denchi, E. L., Danovi, D., Jochemsen, A., Capillo, M., Gobbi, A., Helin, K., Pelicci, P. G., & Marine, J.-C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5527-5538.2002 · Cited by 313
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600812 · Cited by 260 · cited 2×
“A higher amount of Mdm2 would both degrade the extra p53 protein and also the other negative regulator of p53, MdmX GENES & DEVELOPMENT 127 (Chen et al. 2005; Okamoto et al. 2005; Pereg et al. 2005), thus bringing p53 down to levels found in wild-type cells, but such p53 would be relatively more…”
BackgroundLundgren, K., Montes de Oca Luna, R., McNeill, Y. B., Emerick, E. P., Spencer, B., Barfield, C. R., Lozano, G., Rosenberg, M. P., & Finlay, C. A. (1997) · Genes & Development · doi:10.1101/gad.11.6.714 · Cited by 235 · cited 1×
“…leads to increased cellular hypertrophy and nuclear abnormalities as well as an increase in tumor formation (albeit at low penetrance), further supporting the idea that elevated Mdm2 expression even in the context of wild-type p53 can positively affect tumor progression (Lundgren et al. 1997).”
BackgroundTumor suppression and normal aging in mice with constitutively high p53 activity
Mendrysa, S. M., O'Leary, K. A., McElwee, M. K., Michalowski, J., Eisenman, R. N., Powell, D. A., & Perry, M. E. (2006) · Genes & Development · doi:10.1101/gad.1378506 · Cited by 210 · cited 6×
“Having demonstrated largely if not exclusively p53dependent phenotypes of the hypomorphic allele of mdm2, Mendrysa et al. (2006) went on to exploit this experimental system to further examine the physiological consequences of mdm2 down-regulation.”
BackgroundMethodResultInfluentialPhosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage
Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408595102 · Cited by 181
Okamoto, K., Kashima, K., Pereg, Y., Ishida, M., Yamazaki, S., Nota, A., Teunisse, A., Migliorini, D., Kitabayashi, I., Marine, J.-C., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9608-9620.2005 · Cited by 129
Self-citation
Cited by
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
“A wealth of studies have delved into their interactions with p53 and have been well reviewed (Marine et al., 2006, 2007; Poyurovsky and Prives, 2006; Toledo and Wahl, 2006).”
BackgroundSelf-citationVousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
Self-citationp53 Activation by Knockdown Technologies
Robu, M. E., Larson, J. D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S. A., & Ekker, S. C. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030078 · Cited by 999
Metadata
- Authors
- Poyurovsky, M. V., & Prives, C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2006-01-15
- Volume
- 20
- Issue
- 2
- Pages
- 125-131
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2172238284
- Cited by
- 96
- References
- 21
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.